Filtered By:
Management: Centers for Medicare and Medicaid Services (CMS)

This page shows you your search results in order of date.

Order by Relevance | Date

Total 67 results found since Jan 2013.

Here Are the First 10 Drugs Biden Will Target for Price Negotiations
WASHINGTON (AP) — The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs. President Joe Biden’s administration on Tuesday released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer. [time-brightcove not-tgx=”true”] The move is expected to cut costs for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers. It’s also a centerpiece of t...
Source: TIME: Health - August 29, 2023 Category: Consumer Health News Authors: TOM MURPHY, AMANDA SEITZ and CHRIS MEGERIAN / AP Tags: Uncategorized wire Source Type: news

Reply: Stentless versus stented bioprosthetic root replacement in the medicare population and the wisdom of crowds
In our recent analysis of long-term outcomes of aortic root operations in the United States among Medicare beneficiaries using the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD) and Centers for Medicare and Medicaid Services linked data for patients aged 65 years or older undergoing elective aortic root surgery, we concluded that the bioprosthetic Bentall operation should be the procedure of choice in this population due to improved survival and lower stroke risk compared with the use of the mechanical Bentall, and lower risk of aortic valve reintervention compared with valve-sparing aortic root replacement.
Source: The Journal of Thoracic and Cardiovascular Surgery - April 21, 2023 Category: Cardiovascular & Thoracic Surgery Authors: G. Chad Hughes Tags: Letter to the Editor Source Type: research

Reply from the authors: Stentless versus stented bioprosthetic root replacement in the medicare population and the wisdom of crowds
In our recent analysis of long-term outcomes of aortic root operations in the United States among Medicare beneficiaries using the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD) and Centers for Medicare and Medicaid Services linked data for patients aged 65 years or older undergoing elective aortic root surgery, we concluded that the bioprosthetic Bentall operation should be the procedure of choice in this population due to improved survival and lower stroke risk compared with the use of the mechanical Bentall, and lower risk of aortic valve reintervention compared with valve-sparing aortic root replacement.
Source: The Journal of Thoracic and Cardiovascular Surgery - April 21, 2023 Category: Cardiovascular & Thoracic Surgery Authors: G. Chad Hughes Tags: Adult: Aorta: Letters to the Editor Source Type: research

MicroTransponder Secures CMS Transitional Pass-Through Status and New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
AUSTIN, Texas, Jan. 31, 2023 -- (Healthcare Sales & Marketing Network) -- MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services (CMS) awarded the Vivistim® Paired VNS™ System transitional pass-through status, expand... Devices, Neurology, Reimbursement MicroTransponder, Vivistim, Stroke
Source: HSMN NewsFeed - January 31, 2023 Category: Pharmaceuticals Source Type: news

FDA Approves Lecanemab, a New Alzheimer ’s Drug
On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages. Lecanemab, which will be available under the name Leqembi, can slow the cognitive decline associated with Alzheimer’s disease by 27%, according to data submitted to the FDA by the drug’s developers, Eisai and Biogen. It’s only the second medication to show any improvement in neurodegeneration, a key criterion in the FDA’s consideration for approval. “For a long time, this is what we have been looking for,” says Dr. Sam Gandy, professor of neurology and psychi...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news

Hospital Closures Pose Challenges to Care
Empty beds in a hospital room. When 10-bed Nye Regional Medical Center, in west-central Nevada, closed abruptly in 2015, it meant that the residents of the former gold-mining town of Tonopah would have to drive about two hours across a hundred miles of desert roads to get to the nearest hospital.  The hospital’s CEO, Wayne Allen, didn’t sugar-coat it. “This is a decision that will ultimately jeopardize the health and well-being of our community and surrounding areas,” he said. Hospital closures over the last decade—most notably in rural areas and in pediatrics, but urban closures as well—have left patients wi...
Source: The Hospitalist - November 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Business of Medicine Career Pediatrics PHM22 Source Type: research

Rate and Predictors of Acute Care Encounters in the First Month After Stroke
Hospital readmission has become an important quality metric, especially after the Affordable Care Act mandated a reduction in payments to hospitals with readmission rates higher than expected.1 The Centers for Medicare and Medicaid Services (CMS) defines 30-day stroke readmission as a hospital-specific readmission for any cause, except for certain planned readmissions, within 30 days after the date of discharge of the index admission.2 This definition does not take in account patients who are readmitted to other hospitals.
Source: Journal of Stroke and Cerebrovascular Diseases - April 4, 2022 Category: Neurology Authors: Haitham M. Hussein, Ella A. Chrenka, Amanda A. Herrmann Source Type: research

“It's not something that's really been brought up”: Opportunities and challenges for ongoing advance care planning discussions among individuals living with mechanical circulatory support
Advance care planning (ACP) among individuals living with a mechanical circulatory support (MCS) device is complex as the trajectory is typified by recurring life-threatening complications with a limited three-year survival rate of 57%.1 Additionally, 89.2% of MCS patients report experiencing complications such as gastrointestinal bleeding, stroke, and sepsis.2 –4 Against this background, in 2013, the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission required MCS teams to include palliative care consultations to enhance ACP communication early in the trajectory, specifically during the evaluation for MCS surgery.
Source: Heart and Lung - March 23, 2022 Category: Intensive Care Authors: Tiffany Dzou, Jaime D. Moriguchi, Lynn Doering, Jo-Ann Eastwood, Carol Pavlish, Huibrie C. Pieters Source Type: research

National Institutes of Health Stroke Scale Correlates Well with Initial Intracerebral Hemorrhage Volume
The US Centers for Medicare and Medicaid Services (CMS) currently publicly reports hospital-quality, risk-adjusted mortality measure for ischemic stroke but not intracerebral hemorrhage (ICH). The NIHSS, which is captured in CMS administrative claims data, is a candidate metric for use in ICH risk adjustment and has been shown to predict clinical outcome with accuracy similar to the ICH Score. Correlation between early NIHSS and initial ICH volume would further support use of the NIHSS for ICH risk adjustment.
Source: Journal of Stroke and Cerebrovascular Diseases - February 10, 2022 Category: Neurology Authors: Salman Farooq, Kristina Shkirkova, Pablo Villablanca, Nerses Sanossian, David S. Liebeskind, Sidney Starkman, Gilda Avila, Latisha Sharma, May Kim-Tenser, Suzie Gasparian, Marc Eckstein, Robin Conwit, Scott Hamilton, Jeffrey L. Saver Tags: Original Article Source Type: research

Quality Improvement Metrics and Methods for Neurohospitalists
Measurement of clinical performance is largely driven by the requirements of the Centers for Medicare and Medicaid Services and accrediting bodies like The Joint Commission. Performance measures include length of stay, readmission rate, mortality rate, hospital-acquired complications, and stroke core measures. Hospital rankings also depend heavily on quality and patient safety indicators. Becoming facile with these measures can aid neurohospitalists in understanding their value and garnering resources to support improvement projects. Neurohospitalists can apply a structured A3-based method to define a clinical problem, per...
Source: Neurologic Clinics - November 17, 2021 Category: Neurology Authors: Kathryn A. Kvam, Eric Bernier, Carl A. Gold Source Type: research

Clinical Artificial Intelligence Applications in Radiology: Neuro
This article illustrates some of these applications. This article reviews machine learning challenges related to neuroradiology. The first approval of reimbursement for an AI algorithm by the Centers for Medicare and Medicaid Services, covering a stroke software for early detection of large vessel occlusion, is also discussed.PMID:34689869 | DOI:10.1016/j.rcl.2021.07.002
Source: Radiologic Clinics of North America - October 25, 2021 Category: Radiology Authors: Felipe Campos Kitamura Ian Pan Suely Fazio Ferraciolli Kristen W Yeom Nitamar Abdala Source Type: research